The European market has experienced a volatile but ultimately positive week, with the pan-European STOXX Europe 600 Index showing modest gains amid easing geopolitical tensions and strong corporate earnings. However, looming threats of increased tariffs from the U.S. have added pressure to the markets, creating an environment where insider ownership can be a reassuring factor for investors looking at growth companies. In such conditions, stocks with high insider ownership might offer additional confidence to investors due to the alignment of interests between company insiders and shareholders.
Top 10 Growth Companies With High Insider Ownership In Europe
Name
Insider Ownership
Earnings Growth
KebNi (OM:KEBNI B)
11.8%
82.7%
Hacksaw (OM:HACK)
13.2%
24.8%
Envipco Holding (ENXTAM:ENVI)
19.5%
46.5%
Elliptic Laboratories (OB:ELABS)
19.8%
125.1%
Dellia Group (OB:DELIA)
29.9%
63.7%
CTT Systems (OM:CTT)
17.4%
47.1%
Clavister Holding AB (publ.) (OM:CLAV)
18%
83.1%
Circus (XTRA:CA1)
21.9%
84.8%
Bonesupport Holding (OM:BONEX)
10.3%
34.5%
Bergen Carbon Solutions (OB:BCS)
11.9%
56.9%
Let’s review some notable picks from our screened stocks.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Trifork Group AG offers information technology and business services across several countries including Switzerland, Denmark, the United Kingdom, the Netherlands, and the United States, with a market cap of DKK1.70 billion.
Operations: Trifork Group AG’s revenue segments are derived from providing IT and business services across various international markets, including Switzerland, Denmark, the UK, the Netherlands, and the US.
Insider Ownership: 19.9%
Trifork Group is experiencing significant earnings growth, forecasted at 23.2% annually, outpacing the Danish market. Despite a modest revenue increase of 7.8%, its insider ownership aligns with strategic leadership changes and product innovations like Tiris Messenger and Synq, aimed at expanding digital sovereignty and operational efficiency. Recent financials show improved net income to EUR 2.99 million in Q1 2026 from EUR 0.649 million a year prior, underscoring strong growth potential amidst competitive valuations below fair value estimates.
CPSE:TRIFOR Earnings and Revenue Growth as at May 2026
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Humble Group AB (publ) is involved in the development, production, and distribution of fast-moving consumer goods both in Sweden and internationally, with a market cap of SEK3.27 billion.
Story continues
Operations: The company’s revenue is primarily derived from four segments: Future Snacking (SEK1.31 billion), Sustainable Care (SEK2.30 billion), Quality Nutrition (SEK1.68 billion), and Nordic Distribution (SEK3.10 billion).
Insider Ownership: 26.5%
Humble Group shows promising growth potential with forecasted earnings growth of 55.41% annually, surpassing the Swedish market average. Despite a decrease in profit margins from 1.2% to 0.4%, recent Q1 results reveal improved net income of SEK 28 million and stable sales growth to SEK 1,994 million. The company secured a new SEK 2 billion credit facility, enhancing financial stability for future expansion while insiders have increased their holdings recently, indicating confidence in its strategic direction.
OM:HUMBLE Ownership Breakdown as at May 2026
Simply Wall St Growth Rating: ★★★★☆☆
Overview: AlzChem Group AG, with a market cap of €1.67 billion, develops, produces, and markets a variety of chemical specialties across Germany, the European Union, other parts of Europe, Asia, the NAFTA region, and internationally.
Operations: Revenue Segments (in millions of €): Specialty Chemicals €200.50, Basic Chemicals €150.75, and Agrochemicals €100.25.
Insider Ownership: 15.5%
AlzChem Group demonstrates solid growth prospects with earnings forecasted to grow by 18.7% annually, outpacing the German market. Recent Q1 results showed increased sales of €148.65 million and net income of €17.96 million, reflecting strong operational performance. The company’s revenue is expected to grow at 11.2% per year, driven by volume effects in Specialty Chemicals, while trading significantly below its estimated fair value suggests potential undervaluation despite no recent insider trading activity noted.
XTRA:ACT Ownership Breakdown as at May 2026 Seize The Opportunity
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Companies discussed in this article include CPSE:TRIFOR OM:HUMBLE and XTRA:ACT.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com